Ledger.Open graph →
SEC Form D · filed October 16, 2025

Pheast Therapeutics, Inc

Offering
$40.0M
Sold
$24.6M
Exemption
Rule 506(b)
Industry
Other Technology
Location
REDWOOD CITY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Steven Gillis · Ann Arbor, MIDirectorIrving Weissman · Palo Alto, CADirectorRoy Maute · Redwood City, CAExec · DirectorRaphael Rousseau · Redwood City, CAExecJacob Vogelstein · Baltimore, MDDirectorAmira Barkal · Palo Alto, CADirectorThomas Marty · Redwood City, CAExecIrving Weissman · Palo Alto, CADirectorRoy Maute · Redwood City, CAExec · DirectorRaphael Rousseau · Redwood City, CAExecSteven Gillis · Chicago, ILDirectorJacob Vogelstein · Baltimore, MDDirectorAmira Barkal · Palo Alto, CADirectorThomas Marty · Redwood City, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗